NDC 50458-563 – Invega Sustenna
Paliperidone Palmitate 156 mg/mL · Injection · Intramuscular
Product NDC50458-563
Product details
- Brand name
- Invega Sustenna
- Generic name
- Paliperidone palmitate
- Labeler
- Janssen Pharmaceuticals, Inc.
- Dosage form
- Injection
- Route
- Intramuscular
- Marketing category
- NDA · NDA022264
- Marketed since
- July 31, 2009
- Listing expires
- December 31, 2026
- Pharmacologic class
- Atypical Antipsychotic
Active ingredients
- Paliperidone Palmitate 156 mg/mL
Uses, dosage, side effects and warnings for Invega Sustenna →
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 50458-563-01 | 1 SYRINGE in 1 KIT (50458-563-01) / 1 mL in 1 SYRINGE | Jul 31, 2009 |
| 50458-563-03 sample | 1 SYRINGE in 1 KIT (50458-563-03) / 1 mL in 1 SYRINGE | Jul 31, 2009 |
Other Invega Sustenna products
- 50458-560 Paliperidone Palmitate 39 mg/.25mL · Injection · Janssen Pharmaceuticals, Inc.
- 50458-561 Paliperidone Palmitate 78 mg/.5mL · Injection · Janssen Pharmaceuticals, Inc.
- 50458-562 Paliperidone Palmitate 117 mg/.75mL · Injection · Janssen Pharmaceuticals, Inc.
- 50458-564 Paliperidone Palmitate 234 mg/1.5mL · Injection · Janssen Pharmaceuticals, Inc.